Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Salsalate Therapy to Reduce Insulin Resistance and Cardiovascular Risk

NCT00330733 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT00330733
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00330733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Salsalate Therapy to Reduce Insulin Resistance and Cardiovascular Risk
Lead sponsor
VA Office of Research and Development
Phase
Phase 2/3
Overall status
Completed
Start date
January 31, 2007
Completion date
September 30, 2010
Enrollment
71 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, cardiovascular disease, inflammation, insulin resistance, noninsulin-dependent diabetes mellitus